|
After 52 Weeks, Pitavastatin is Superior to
Pravastatin for LDL-C Lowering in Patients with HIV
|
|
|
Reported by Jules Levin
Late Breaker Poster presented at the CROI 2014 Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, MA, USA.
Craig A. Sponseller1, Vladimir A. Kryzhanovski2 , Roger E. Morgan3, Stuart E. Campbell3, Melanie A. Thompson4, Judith A. Aberg5
1Kowa Pharmaceuticals America, Inc., Montgomery, AL; 2Eli Lilly and Company, Indianapolis, IN; 3Kowa Research Institute, Inc., Morrisville, NC; 4AIDS Research Consortium of Atlanta, GA; 5ICAHN School of Medicine at Mount Sinai, New York, NY
Research sponsored by Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company.
![1222161](../images/122116/122216-8/1222161.gif)
![1222162](../images/122116/122216-8/1222162.gif)
![1222163](../images/122116/122216-8/1222163.gif)
![1222164](../images/122116/122216-8/1222164.gif)
![1222165](../images/122116/122216-8/1222165.gif)
![1222166](../images/122116/122216-8/1222166.gif)
![1222167](../images/122116/122216-8/1222167.gif)
![1222168](../images/122116/122216-8/1222168.gif)
![1222169](../images/122116/122216-8/1222169.gif)
![12221610](../images/122116/122216-8/12221610.gif)
|
|
|
|
|
|
|